As of November 2024 Akebia Therapeutics has a market cap of £0.31 Billion. This makes Akebia Therapeutics the world's 7056th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 18th, 2024 the market cap of Akebia Therapeutics was reported to be: